Shrinidh Joshi

514 total citations
17 papers, 385 citations indexed

About

Shrinidh Joshi is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Shrinidh Joshi has authored 17 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Cancer Research. Recurrent topics in Shrinidh Joshi's work include Angiogenesis and VEGF in Cancer (6 papers), Renin-Angiotensin System Studies (6 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Shrinidh Joshi is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Renin-Angiotensin System Studies (6 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Shrinidh Joshi collaborates with scholars based in United States, India and China. Shrinidh Joshi's co-authors include Krutika Sawant, Sandip S. Chavhan, Yagna Jarajapu, Goutham Vasam, Estelle Leclerc, Narayanaganesh Balasubramanian, Sean E. Thatcher, Lirong Guo, Neha Singh and Matthew B. Baker and has published in prestigious journals such as Diabetes, Scientific Reports and The FASEB Journal.

In The Last Decade

Shrinidh Joshi

17 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shrinidh Joshi United States	8	109	101	70	67	59	17	385
Baoan Gao China	12	138 1.3×	46 0.5×	53 0.8×	15 0.2×	34 0.6×	21	336
Maria do Céu Monteiro Portugal	9	118 1.1×	62 0.6×	31 0.4×	65 1.0×	6 0.1×	27	356
Johanna J. Salomon Germany	15	163 1.5×	62 0.6×	33 0.5×	7 0.1×	27 0.5×	24	550
Jinping Wang China	13	116 1.1×	29 0.3×	16 0.2×	123 1.8×	35 0.6×	38	508
Blenda Wong Hong Kong	13	186 1.7×	64 0.6×	80 1.1×	7 0.1×	18 0.3×	14	492
Kazuko Kamiyama Japan	13	280 2.6×	21 0.2×	39 0.6×	23 0.3×	14 0.2×	18	500
Xiaochuan Tan China	7	129 1.2×	57 0.6×	49 0.7×	21 0.3×	4 0.1×	13	368
Honglei Guo China	12	235 2.2×	18 0.2×	30 0.4×	26 0.4×	10 0.2×	27	485
Youmin Wang China	14	147 1.3×	58 0.6×	12 0.2×	42 0.6×	5 0.1×	45	459
Parmeshwar B. Katare India	12	240 2.2×	12 0.1×	62 0.9×	79 1.2×	10 0.2×	19	529

Countries citing papers authored by Shrinidh Joshi

Since Specialization

Citations

This map shows the geographic impact of Shrinidh Joshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shrinidh Joshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shrinidh Joshi more than expected).

Fields of papers citing papers by Shrinidh Joshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shrinidh Joshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shrinidh Joshi. The network helps show where Shrinidh Joshi may publish in the future.

Co-authorship network of co-authors of Shrinidh Joshi

This figure shows the co-authorship network connecting the top 25 collaborators of Shrinidh Joshi. A scholar is included among the top collaborators of Shrinidh Joshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shrinidh Joshi. Shrinidh Joshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Joshi, Shrinidh, et al.. (2024). The role of telomerase reverse transcriptase in the mitochondrial protective functions of Angiotensin-(1–7) in diabetic CD34+ cells. Biochemical Pharmacology. 222. 116109–116109. 1 indexed citations

Joshi, Shrinidh, et al.. (2022). Transforming growth factor-β1/Thrombospondin-1/CD47 axis mediates dysfunction in CD34+ cells derived from diabetic older adults. European Journal of Pharmacology. 920. 174842–174842. 2 indexed citations

Hefnawy, Amr, et al.. (2022). Design Validation of a Smart Inhaler Device with an Integrated Spacer for Enhanced Aerosolization Performance. Journal of Pharmaceutical Innovation. 18(2). 789–793. 3 indexed citations

Joshi, Shrinidh, et al.. (2021). ACE2 gene transfer ameliorates vasoreparative dysfunction in CD34+ cells derived from diabetic older adults. Clinical Science. 135(2). 367–385. 7 indexed citations

Joshi, Shrinidh, et al.. (2020). ACE2/ACE imbalance and impaired vasoreparative functions of stem/progenitor cells in aging. GeroScience. 43(3). 1423–1436. 11 indexed citations

Joshi, Shrinidh, et al.. (2020). Blood flow restriction exercise stimulates mobilization of hematopoietic stem/progenitor cells and increases the circulating ACE2 levels in healthy adults. Journal of Applied Physiology. 128(5). 1423–1431. 19 indexed citations

Joshi, Shrinidh, et al.. (2019). Hypoxic regulation of angiotensin‐converting enzyme 2 and Mas receptor in human CD34⁺ cells. Journal of Cellular Physiology. 234(11). 20420–20431. 50 indexed citations

Joshi, Shrinidh, et al.. (2019). Aging Healthy, or with Diabetes, is Associated with ACE2/ACE Imbalance in the Hematopoietic Stem Progenitor Cells. The FASEB Journal. 33(S1). 5 indexed citations

Joshi, Shrinidh, Estelle Leclerc, & Yagna Jarajapu. (2018). Abstract P244: Hypoxic Stimulation of Vasoreparative Functions in Human CD34 ⁺ cells is Mediated by Angiotensin Converting Enzyme-2 and Mas Receptor. Hypertension. 72(Suppl_1). 1 indexed citations

10.

Joshi, Shrinidh & Yagna Jarajapu. (2018). Mitochondrial depolarization stimulates vascular repair‐relevant functions of CD34⁺ cells via reactive oxygen species‐induced nitric oxide generation. British Journal of Pharmacology. 176(22). 4373–4387. 6 indexed citations

11.

Jarajapu, Yagna, et al.. (2017). Abstract 011: ACE2 Gene Transfer Ameliorates Dysfunctions in Hematopoietic Stem/Progenitor Cells of Diabetic Patients. Hypertension. 70(suppl_1). 1 indexed citations

12.

Joshi, Shrinidh & Yagna Jarajapu. (2017). Activation of Mitochondrial K _ATP Channels by Diazoxide Stimulates Vascular Repair‐Relevant Functions of Human CD34 ⁺ Cells by Activating Endothelial Nitric Oxide Synthase. The FASEB Journal. 31(S1). 1 indexed citations

13.

Joshi, Shrinidh, Narayanaganesh Balasubramanian, Goutham Vasam, & Yagna Jarajapu. (2016). Angiotensin converting enzyme versus angiotensin converting enzyme-2 selectivity of MLN-4760 and DX600 in human and murine bone marrow-derived cells. European Journal of Pharmacology. 774. 25–33. 36 indexed citations

14.

Vasam, Goutham, Shrinidh Joshi, & Yagna Jarajapu. (2016). Impaired Mobilization of Vascular Reparative Bone Marrow Cells in Streptozotocin-Induced Diabetes but not in Leptin Receptor-Deficient db/db Mice. Scientific Reports. 6(1). 26131–26131. 9 indexed citations

15.

Vasam, Goutham, Shrinidh Joshi, Sean E. Thatcher, et al.. (2016). Reversal of Bone Marrow Mobilopathy and Enhanced Vascular Repair by Angiotensin-(1-7) in Diabetes. Diabetes. 66(2). 505–518. 22 indexed citations

16.

Singh, Neha, Shrinidh Joshi, Lirong Guo, et al.. (2015). ACE2/Ang-(1–7)/Mas axis stimulates vascular repair-relevant functions of CD34⁺cells. American Journal of Physiology-Heart and Circulatory Physiology. 309(10). H1697–H1707. 32 indexed citations

17.

Joshi, Shrinidh, Sandip S. Chavhan, & Krutika Sawant. (2010). Rivastigmine-loaded PLGA and PBCA nanoparticles: Preparation, optimization, characterization, in vitro and pharmacodynamic studies. European Journal of Pharmaceutics and Biopharmaceutics. 76(2). 189–199. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact